0001683168-17-000666.txt : 20170327 0001683168-17-000666.hdr.sgml : 20170327 20170327160512 ACCESSION NUMBER: 0001683168-17-000666 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170327 DATE AS OF CHANGE: 20170327 EFFECTIVENESS DATE: 20170327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rennova Health, Inc. CENTRAL INDEX KEY: 0000931059 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 680370244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-283386 FILM NUMBER: 17715409 BUSINESS ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-855-1626 MAIL ADDRESS: STREET 1: 400 S. AUSTRALIAN AVENUE, SUITE 800 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 FORMER COMPANY: FORMER CONFORMED NAME: CollabRx, Inc. DATE OF NAME CHANGE: 20120926 FORMER COMPANY: FORMER CONFORMED NAME: TEGAL CORP /DE/ DATE OF NAME CHANGE: 19950918 D 1 primary_doc.xml X0707 D LIVE 0000931059 Rennova Health, Inc. 400 SOUTH AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH FL FLORIDA 33401 561-855-1626 DELAWARE None CollabRx, Inc. TEGAL CORP /DE/ Corporation true Seamus Lagan 400 S. Australian Avenue, Suite 800 West Palm Beach FL FLORIDA 33401 Executive Officer Director Paul Billings 400 S. Australian Avenue, Suite 800 West Palm Beach FL FLORIDA 33401 Director Christopher Diamantis 400 S. Australian Avenue, Suite 800 West Palm Beach FL FLORIDA 33401 Director Michael L Goldberg 400 S. Australian Avenue, Suite 800 West Palm Beach FL FLORIDA 33401 Director Robert Lee 400 S. Australian Avenue, Suite 800 West Palm Beach FL FLORIDA 33401 Director Other Health Care Decline to Disclose 06b false 2017-03-13 false true false 1 848000 848000 0 Holders of $440,000 principal amount of convertible notes and warrants exchanged such securities for an aggregate of 400,000 shares of common stock (closing price on 3/13/2017 was $2.12 per share). false 2 0 0 0 The shares of common stock are being issued in exchange for convertible notes and warrants. No gross proceeds will be received upon the issuance of the shares of common stock. false Rennova Health, Inc. /s/ Seamus Lagan Seamus Lagan Chief Executive Officer 2017-03-27